ICU Medical Sees Unusually Large Options Volume (NASDAQ:ICUI)

ICU Medical, Incorporated (NASDAQ:ICUI) was the target of unusually large options trading activity on Thursday. Stock investors bought 685 call options on the company. This is an increase of 1,102% compared to the typical volume of 57 call options.

NASDAQ ICUI opened at $214.00 on Friday. ICU Medical has a 52 week low of $148.89 and a 52 week high of $259.72. The firm has a market capitalization of $4.42 billion, a price-to-earnings ratio of 63.31 and a beta of 0.93. The company has a fifty day moving average of $192.03 and a two-hundred day moving average of $178.68.

Several equities research analysts have weighed in on ICUI shares. BidaskClub raised ICU Medical from a “hold” rating to a “buy” rating in a research note on Friday, February 7th. ValuEngine raised ICU Medical from a “hold” rating to a “buy” rating in a research note on Friday, January 3rd. Zacks Investment Research upgraded ICU Medical from a “sell” rating to a “hold” rating in a report on Tuesday, January 14th. Finally, Raymond James boosted their target price on ICU Medical from $185.00 to $203.00 and gave the company a “positive” rating in a research report on Tuesday, November 12th. One research analyst has rated the stock with a hold rating and three have assigned a buy rating to the stock. The stock currently has a consensus rating of “Buy” and a consensus price target of $242.00.

In related news, VP Virginia Ruth Sanzone sold 2,487 shares of the stock in a transaction dated Monday, February 3rd. The shares were sold at an average price of $182.13, for a total value of $452,957.31. Following the completion of the transaction, the vice president now owns 55 shares of the company’s stock, valued at approximately $10,017.15. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, CFO Scott E. Lamb sold 9,185 shares of the stock in a transaction dated Monday, December 9th. The shares were sold at an average price of $180.58, for a total transaction of $1,658,627.30. Following the completion of the transaction, the chief financial officer now directly owns 22,494 shares of the company’s stock, valued at approximately $4,061,966.52. The disclosure for this sale can be found here. Insiders sold a total of 31,940 shares of company stock valued at $5,846,715 over the last three months. Corporate insiders own 11.40% of the company’s stock.

Several institutional investors and hedge funds have recently made changes to their positions in ICUI. BlackRock Inc. boosted its stake in shares of ICU Medical by 4.9% during the 2nd quarter. BlackRock Inc. now owns 1,558,317 shares of the medical instruments supplier’s stock worth $392,555,000 after purchasing an additional 72,346 shares during the period. State of Alaska Department of Revenue boosted its position in shares of ICU Medical by 86.7% during the third quarter. State of Alaska Department of Revenue now owns 3,415 shares of the medical instruments supplier’s stock valued at $545,000 after buying an additional 1,586 shares during the period. Pacer Advisors Inc. boosted its position in shares of ICU Medical by 4.6% during the third quarter. Pacer Advisors Inc. now owns 6,912 shares of the medical instruments supplier’s stock valued at $1,103,000 after buying an additional 306 shares during the period. Nisa Investment Advisors LLC grew its stake in shares of ICU Medical by 10.0% during the third quarter. Nisa Investment Advisors LLC now owns 11,550 shares of the medical instruments supplier’s stock valued at $1,843,000 after buying an additional 1,050 shares during the last quarter. Finally, State of Michigan Retirement System grew its stake in shares of ICU Medical by 14.3% during the third quarter. State of Michigan Retirement System now owns 5,600 shares of the medical instruments supplier’s stock valued at $894,000 after buying an additional 700 shares during the last quarter. 91.84% of the stock is currently owned by institutional investors and hedge funds.

ICU Medical Company Profile

ICU Medical, Inc develops, manufactures, and sells medical devices used in vascular therapy, critical care, and oncology applications worldwide. It offers infusion therapy products comprising a tube running from a bottle or plastic bag containing a solution to a catheter inserted in a patient's vein.

Featured Story: How does the Beige Book influence monetary policy?

Receive News & Ratings for ICU Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical and related companies with MarketBeat.com's FREE daily email newsletter.